Practical consensus recommendations on management of triple-negative metastatic breast cancer

Patients with breast cancer along with metastatic estrogen and progesterone receptor (ER/PR)- and human epidermal growth factor receptor 2 (HER2)-negative tumors are referred to as having metastatic triple-negative breast cancer (mTNBC) disease. Resistance to current standard therapies such as anthr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:South Asian J Cancer
Autors principals: Rangarao, R., Smruti, B. K., Singh, K., Gupta, A., Batra, S., Choudhary, R. K., Sahani, S., Kabra, Vedant, Parikh, Purvish M., Aggarwal, S.
Format: Artigo
Idioma:Inglês
Publicat: Medknow Publications & Media Pvt Ltd 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5909290/
https://ncbi.nlm.nih.gov/pubmed/29721479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/sajc.sajc_118_18
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars